About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Comparison of Two Intermittent Urinary Catheters | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01284361

Comparison of Two Intermittent Urinary Catheters

This is an unblinded, multi-center, randomized, controlled, cross-over study assessing wheel-chair bound, male user preference and catheter characteristics of two intermittent urinary catheters. Subje...

Lead sponsor: Hollister Incorporated•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hollister Incorporated

1. is male and at least 18 years of age. 2. is self-catheterizing at least 3 times a day. 3. has been performing catheterizations for at least 2 months. 4. is wheelchair bound. 5. is able to use a size 12 or 14 French straight catheter. 6. is willing and able to follow the study protocol and Investigator's instructions. 7. is in the opinion of the Investigator, qualified to participate.

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•is male and at least 18 years of age
•is self-catheterizing at least 3 times a day
•has been performing catheterizations for at least 2 months
•wheelchair bound
•is able to use a size 12 or 14 French straight catheter
•is willing and able to follow the study protocol and Investigator's instructions
•is, in the opinion of the Investigator, qualified to participate

Exclusion Criteria

•has cognitive impairments that preclude completion of study protocol
•cannot communicate as determined by the Investigator
•has an existing medical condition that, in the opinion of the investigator, would interfere with the subject's ability to participate or in the interpretation of the results
•has a symptomatic urinary tract infection determined by interview
•has a retracted penis
•has participated in a study during the previous 30 days involving catheterization
•has been diagnosed with an enlarged prostate
•has urethral strictures, false passages, or urethral obstruction

Related studies

RECRUITINGPhase 4

Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention

NCT07650968 · Acute Urinary Retention, Benign Prostatic Hyperplasia

Effect of Catheter Duration on Prostate Laser Enucleation Surgery Outcomes in Patients With Urinary Retention

NCT07603011 · Urinary Retention, Benign Prostate Obstruction (BPO)

RECRUITINGPhase 2

Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

NCT04597372 · Urinary Retention Postoperative

RECRUITINGEARLY Phase 1

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

NCT05657990 · Urinary Retention

How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding

NCT07125326 · Urinary Retention, Urinary Tract Infection (Diagnosis), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 1, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment91

Start dateOct 2010

Last updatedFeb 1, 2017

Condition

Urinary Retention

Locations shown

Shepherd Center and Crawford Research Institute

Atlanta, Georgia

Mark Drug Medical Supply

Wheeling, Illinois

Restored Images

Kansas City, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 1, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions